SCHEMBL3850586

SCHEMBL3850586

CN1CCN(c2ccc3nc(-c4cc(-c5ccc(N(C(N)=O)c6cccc(Br)c6)cc5)[nH]n4)[nH]c3c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.46
BRD4 O60885 7/20 0.45
TOP1 P11387 2/20 0.45
TOP2A P11388 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
FGFR1 P11362 4/20 0.44
KDR P35968 3/20 0.44
FGFR2 P21802 2/20 0.44
FGFR3 P22607 2/20 0.44
PDGFRB P09619 2/20 0.44
AURKA O14965 1/20 0.44
JAK2 O60674 1/20 0.44
FGFR4 P22455 1/20 0.44
FLT3 P36888 1/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3842420 0.85 PRKD1 (0.43) BRD4TOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL15104126 0.84 PRKD1 (0.46) BRD4PRKD1MELK
SCHEMBL3850883 0.82 BRD4 (0.46) BRD4TOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL1790845 0.82 PRKD1 (0.54) RETBRD4TOP1TOP2AALDH1A1
SCHEMBL1790719 0.73 PRKD1 (0.52) BRD4TOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL1788454 0.72 DGAT1 (0.55) BRD4TOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL1790220 0.72 KDR (0.59) BRD4TOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL5523487 0.72 ALDH1A1 (0.57) RETTOP1TOP2AALDH1A1SMN1; SMN2
SCHEMBL5531729 0.70 MELK (0.57) KDRAURKAFLT3FLT1PRKD1
SCHEMBL27802443 0.70 PRKD1 (0.51) SMN1; SMN2FLT3PRKD1MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797072-A4 PYRAZOLE KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-09-09 EP disclosed
EP-1797072-A2 PYRAZOLE KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2007-06-20 EP disclosed
WO-2006033943-A2 PYRAZOLE KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC (US) 2006-03-30 WO disclosed